US Patent Issued to Azura Ophthalmics on Nov. 4 for "Selenium disulfide compositions for use in treating meibomian gland dysfunction" (Israeli Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,661, issued on Nov. 4, was assigned to Azura Ophthalmics Ltd. (Tel Aviv, Israel).

"Selenium disulfide compositions for use in treating meibomian gland dysfunction" was invented by Doron Friedman (Carme-Yosrf, Israel), Yair Alster (Tel Aviv, Israel), Omer Rafaeli (Udim, Israel), Shimon Amselem (Rehovot, Israel) and Zakhar Nudelman (Netanya, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said methods are performed by administering said composition comprising a selenium disulfide and an anhydrous semi-solid base. The stable anhydrous composition are su...